Get the Stockscreener App
38.54
0.26%
-0.11
Enovis Corp stock is traded at $38.54, with a volume of 681.00K.
It is down -0.26% in the last 24 hours and down -14.84% over the past month.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
See More
Previous Close:
$38.65
Open:
$39.18
24h Volume:
681.00K
Relative Volume:
0.90
Market Cap:
$2.21B
Revenue:
$2.00B
Net Income/Loss:
$-119.19M
P/E Ratio:
-17.60
EPS:
-2.19
Net Cash Flow:
$-61.88M
1W Performance:
-11.44%
1M Performance:
-14.84%
6M Performance:
-13.51%
1Y Performance:
-36.15%
1-Day Range:
$38.58
$39.50
1-Week Range:
$37.60
$43.75
52-Week Range:
$37.60
$63.96
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
38.58 | 2.21B | 2.00B | -119.19M | -61.88M | -2.19 |
|
ETN
Eaton Corporation Plc
|
284.00 | 134.74B | 24.88B | 3.79B | 3.23B | 9.50 |
|
PH
Parker Hannifin Corp
|
661.30 | 85.20B | 19.91B | 3.16B | 3.30B | 24.16 |
|
ITW
Illinois Tool Works Inc
|
264.21 | 77.64B | 15.90B | 3.49B | 2.84B | 11.72 |
|
EMR
Emerson Electric Co
|
120.61 | 68.28B | 17.55B | 2.41B | 3.27B | 4.19 |
|
CMI
Cummins Inc
|
364.32 | 50.79B | 34.10B | 3.95B | 279.00M | 28.17 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-24 | Initiated | JP Morgan | Neutral |
| Feb-13-24 | Initiated | Stephens | Overweight |
| Jan-22-24 | Initiated | UBS | Buy |
| Jan-03-24 | Initiated | William Blair | Outperform |
| Dec-15-23 | Reiterated | Needham | Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Jun-26-23 | Initiated | Needham | Buy |
| May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-11-22 | Initiated | Goldman | Buy |
| Sep-12-22 | Initiated | Canaccord Genuity | Buy |
| Sep-12-22 | Initiated | Evercore ISI | Outperform |
| Jun-28-22 | Initiated | Argus | Hold |
| Jun-27-22 | Resumed | Loop Capital | Buy |
| Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
William Blair Issues Optimistic Outlook for Enovis Earnings - MarketBeat
Enovis (NYSE:ENOV) Issues FY 2025 Earnings Guidance - MarketBeat
Enovis (ENOV) Q4 Earnings and Revenues Surpass Estimates - MSN
Enovis Positioned for Growth: Buy Rating Backed by Strong Sales, Product Launches, and Attractive Valuation - TipRanks
Enovis (NYSE:ENOV) Reaches New 1-Year Low on Analyst Downgrade - MarketBeat
Enovis Corporation Reports Strong Growth Amid Challenges - MSN
Enovis Reports Strong 2024 Sales Growth Despite Goodwill Impairment Charge - MSN
Needham & Company LLC Has Lowered Expectations for Enovis (NYSE:ENOV) Stock Price - MarketBeat
Enovis Continues To Languish Despite Decent Financial Results (NYSE:ENOV) - Seeking Alpha
Diabetic Footwear Market Future Business Opportunities 2025-2032 | Enovis companies, Pilgrim Shoes, Drew Shoe - EIN News
Decoding Enovis Corp (ENOV): A Strategic SWOT Insight - GuruFocus.com
Enovis (NYSE:ENOV) Issues Quarterly Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat
Enovis Corporation (NYSE:ENOV) Q4 2024 Earnings Call Transcript - Insider Monkey
Enovis CEO Matt Trerotola Announces Retirement, Leadership Transition Underway - MSN
Rhumbline Advisers Acquires 1,938 Shares of Enovis Co. (NYSE:ENOV) - Defense World
Enovis Corp (ENOV) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook - Yahoo Finance
Enovis’s Strong Financial Performance and Strategic Positioning Earns Buy Rating - TipRanks
Enovis Corporation Faces Financial Strain Amid U.S.-China Tariff Uncertainty - TipRanks
Enovis Corporation Reports Strong Sales Growth Amid Challenges - TipRanks
Enovis: Strong Financial Performance and Growth Potential Justify Buy Rating - TipRanks
Enovis: Q4 Earnings Snapshot - CT Insider
Enovis Announces Fourth Quarter and Full Year 2024 Results - OrthoSpineNews
Enovis plans CEO succession - Mass Device
Earnings call transcript: Enovis beats Q4 2024 EPS forecast, stock dips - Investing.com
Enovis earnings beat by $0.07, revenue topped estimates - Investing.com
Enovis (NYSE:ENOV) Exceeds Q4 Expectations By Stock Story - Investing.com Canada
Matt Trerotola Plans to Retire as Chief Executive Officer of Enovis Corporation -February 26, 2025 at 06:00 am EST - Marketscreener.com
Enovis CORP SEC 10-K Report - TradingView
Matt Trerotola Announces Retirement From Enovic - citybiz
Enovis Issues 2025 Guidance - Nasdaq
Enovis (NYSE:ENOV) Exceeds Q4 Expectations - Yahoo Finance
Enovis CEO Matt Trerotola to retire, board seeks replacement - TipRanks
ENOVIS Earnings Results: $ENOV Reports Quarterly Earnings - Nasdaq
Enovis CEO Retirement and Leadership Transition Announced - TipRanks
Enovis: Q4 Earnings Snapshot -February 26, 2025 at 06:23 am EST - Marketscreener.com
Enovis Announces Planned CEO Succession Process - The Manila Times
Enovis Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Set -February 26, 2025 at 06:17 am EST - Marketscreener.com
Enovis Corporation Q4 Earnings Summary - Nasdaq
Enovis reports Q4 adjusted EPS 98c, consensus 92c - TipRanks
Enovis CEO Matt Trerotola to Retire - MarketWatch
Earnings Flash (ENOV) ENOVIS CORPORATION Posts Q4 Revenue $561M, vs. FactSet Est of $555.1M - Marketscreener.com
Earnings Flash (ENOV) ENOVIS CORPORATION Posts Q4 Adjusted EPS $0.98 Per Share, vs. FactSet Est of $0.92 - Marketscreener.com
Enovis Announces CEO Retirement: Will the Leadership Change Impact Its MedTech Growth Strategy? - StockTitan
Enovis Corporation Q4 2024 Earnings Preview - MSN
Enovis (ENOV) Q4 Earnings: What To Expect - The Globe and Mail
Enovis Corporation Anticipates Earnings Report Amid Market ChallengesNews and Statistics - IndexBox, Inc.
Enovis (ENOV) Q4 Earnings: What To Expect By Stock Story - Investing.com Canada
Enovis (NYSE:ENOV) investors are sitting on a loss of 38% if they invested three years ago - Simply Wall St
State of New Jersey Common Pension Fund D Boosts Stock Position in Enovis Co. (NYSE:ENOV) - Defense World
Enovis (ENOV) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Enovis Co. (NYSE:ENOV) Sees Large Drop in Short Interest - MarketBeat
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):